|
Market Cap (4-Jul) $10,319,610 (791st) |
Close (30-Jun) $0.022 |
Volume (30-Jun) 1,033,118 |
Shortsold (7-Aug) 1,552,633 (0.26%) (384th) |
|
52w High $0.028 |
52w Low $0.014 |
P/E 54.95 |
EPS -0.01 |
AT1 released this announcement to the ASX on 29 July 2021, 8:26. The announcement is marked as price sensitive, and is 5 page(s) in length and 874.74kb in size.
You can view all announcements from AT1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, AT1 was 0.075% short sold according to ASIC data. It was ranked the 468th most shorted stock on the ASX. It is now ranked as the 384th most shorted stock on the ASX with 0.256% of total shares short sold as of the latest reported data (07 August 2023).
| Other Recent Announcements from AT1 | |
|---|---|
| Ceasing to be a substantial holder | 23 June 2023, 16:26 |
| Exclusive Agreement for HIV Testing Signed with Newfoundland | 14 June 2023, 9:54 |
| Change in substantial holding | 6 June 2023, 18:02 |
| Appendix 4C - 30 June 2021 | 29 July 2021, 8:26 |
| Change in substantial holding | 1 July 2021, 15:21 |
| Access Bio receives FDA clearance for COVID-19 antibody test | 28 June 2021, 8:18 |
| Proposed issue of Securities - AT1 | 30 April 2021, 13:15 |
You must be logged in to post a reply.
